Brevan Howard Capital Management’s Concentrix CNXC Stock Holding History

Brevan Howard Capital Management’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$728K	Buy	32,480 +6,128	+23%	+$160K	0.01%	1240
2026 Q1	$721K	Sell	26,352 -27,007	-51%	-$958K	0.01%	1091
2025 Q4	$2.22M	Buy	53,359 +33,559	+169%	+$1.36M	0.02%	454
2025 Q3	$914K	Buy	19,800 +10,849	+121%	+$579K	﹤0.01%	944
2025 Q2	$473K	Buy	8,951 +384	+4%	+$20.3K	﹤0.01%	1377
2025 Q1	$477K	Sell	8,567 -36,416	-81%	-$1.74M	﹤0.01%	736
2024 Q4	$1.95M	Buy	44,983 +36,723	+445%	+$1.63M	0.01%	287
2024 Q3	$423K	Buy	+8,260	New	+$553K	﹤0.01%	735
2024 Q1	–	Sell	-2,763	Closed	-$271K	–	1049
2023 Q4	$271K	Buy	+2,763	New	+$241K	﹤0.01%	762

Other funds holding CNXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

KGI

Kopernik Global Investors Tampa, Florida $1.63B AUM 27.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Brevan Howard Capital Management's CNXC Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Concentrix (CNXC) stake by 23% in Q2 2026, buying an estimated $160K and bringing the position to 32,480 shares worth $728K. The position accounts for 0.01% of the portfolio, ranked #1240.

Brevan Howard Capital Management first reported a position in CNXC in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.22M in Q4 2025. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

Brevan Howard Capital Management held 32,480 shares of Concentrix worth $728K as of Q2 2026.
Brevan Howard Capital Management bought 6,128 Concentrix shares in Q2 2026, an estimated $160K.
Concentrix made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1240 holding.
Brevan Howard Capital Management first reported a position in Concentrix in Q4 2023 and has held it in 9 quarters since.
Brevan Howard Capital Management's Concentrix position peaked at $2.22M in Q4 2025.
271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.